RSPO2 and colorectal cancer: These data are in line with a previous report showing that Rspo2, but not other family members, through interaction with the Lgr5 receptor, exhibits tumor suppressive activity on colorectal cancer cell lines via negative regulation of the Wnt/β‐catenin pathway 20.